Confocal Fluorescence Microscopy of the Human Airways in Diagnostics of Lung Transplantation
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 6 - 22 |
Updated: | 3/22/2019 |
Start Date: | November 1, 2018 |
End Date: | December 2020 |
Contact: | Levent Midyat, MD |
Email: | levent.midyat@childrens.harvard.edu |
Phone: | 617-355-1900 |
Bronchoscopy-guided tissue sampling is a central technique in many diseases including
diagnosing and staging lung cancers, diagnosing interstitial lung diseases, and acute and/or
chronic rejections following lung transplantation. Confocal fluorescence microscopy is a
novel technique used for real-time microscopic imaging of proximal and distal airways,
microvessels, and inflammatory cells. We hypothesize that confocal fluorescence microscopy
images of airways and alveolar structures during standard bronchoscopy could help recognize
and classify the presence or absence of acute or chronic rejection in lung transplant
recipients.
diagnosing and staging lung cancers, diagnosing interstitial lung diseases, and acute and/or
chronic rejections following lung transplantation. Confocal fluorescence microscopy is a
novel technique used for real-time microscopic imaging of proximal and distal airways,
microvessels, and inflammatory cells. We hypothesize that confocal fluorescence microscopy
images of airways and alveolar structures during standard bronchoscopy could help recognize
and classify the presence or absence of acute or chronic rejection in lung transplant
recipients.
Bronchoscopy-guided tissue sampling is a central technique in many diseases including
diagnosing and staging lung cancers, diagnosing interstitial lung diseases, and acute and/or
chronic rejections following lung transplantation. Confocal fluorescence microscopy is a
novel technique used for in vivo microscopic imaging of proximal and distal airways including
bronchial and alveolar walls, microvessels, and inflammatory cells. We hypothesize that
confocal fluorescence microscopy images of bronchiolar and alveolar structures during
standard bronchoscopy could help recognize and classify the presence or absence of acute or
chronic rejection in lung transplant recipients.
The objectives and outcomes of this study are:
1. To assess the safety of confocal microscopy imaging in pediatric patients
2. To create diagnostic criteria for fibered confocal fluorescence microscopy image
interpretation of acute and chronic rejections following lung transplantation
3. To determine the sensitivity and specificity of confocal imaging in these patient groups
compared to the transbronchial biopsies
4. Correlate confocal images to FEV1 results
5. Correlate with CXRs and/or CT images
diagnosing and staging lung cancers, diagnosing interstitial lung diseases, and acute and/or
chronic rejections following lung transplantation. Confocal fluorescence microscopy is a
novel technique used for in vivo microscopic imaging of proximal and distal airways including
bronchial and alveolar walls, microvessels, and inflammatory cells. We hypothesize that
confocal fluorescence microscopy images of bronchiolar and alveolar structures during
standard bronchoscopy could help recognize and classify the presence or absence of acute or
chronic rejection in lung transplant recipients.
The objectives and outcomes of this study are:
1. To assess the safety of confocal microscopy imaging in pediatric patients
2. To create diagnostic criteria for fibered confocal fluorescence microscopy image
interpretation of acute and chronic rejections following lung transplantation
3. To determine the sensitivity and specificity of confocal imaging in these patient groups
compared to the transbronchial biopsies
4. Correlate confocal images to FEV1 results
5. Correlate with CXRs and/or CT images
Inclusion Criteria:
- to be older than six years of age
- to be undergoing surveillance or clinically indicated bronchoscopies with
transbronchial biopsy as part of their routine care
- to be willing and able to comply with study procedures and provide written informed
consent/assent to participate in the study
Exclusion Criteria:
- to be unwilling to consent
- to be unable to safely tolerate a bronchoscopic procedure
- to have any contraindications to short-acting anesthetic agents
- to have any contraindications to transbronchial biopsies
We found this trial at
1
site
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
Click here to add this to my saved trials